Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes.
Foot problems span everything from wearing the wrong shoes to having a specific foot shape and acquiring infection or nerve ...